Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Locations section reorganized to add California, Georgia, Massachusetts, Ohio, and Texas as locations and to remove the previous state blocks, with the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-24T11:33:36.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The Publications section text was updated to clarify that entries are automatically filled from PubMed and may not pertain to the study; the revision/version label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:00:00.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Deletion removes a general government funding/operating-status notice, while the Study Details content (title, conditions, plan, and eligibility) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:24:53.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:57:36.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    - Added a government funding notice and current operating status information, plus a new version tag v3.2.0. - Removed the term 'Adrenal cortex carcinoma' and the older version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T07:59:11.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T04:37:58.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.